Insider · CIK 0001614578

Lian Brian

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001614578

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-29	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−149K sh	$33.32	−$4.95M	2,572,441
2026-07-28	VKTXViking Therapeutics, Inc.A Award	Director, President & CEO	AAward	+222K sh	—	—	2,720,958
2026-01-05	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−6,400 sh	$35.07	−$224K	2,499,291
2026-01-05	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−41.3K sh	$34.22	−$1.41M	2,505,691
2026-01-05	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−53.3K sh	$33.38	−$1.78M	2,546,967
2026-01-05	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−132K sh	$32.29	−$4.28M	2,600,246
2026-01-02	VKTXViking Therapeutics, Inc.A Award	Director, President & CEO	AAward	+224K sh	—	—	2,732,700
2026-01-02	VKTXViking Therapeutics, Inc.A Award	Director, President & CEO	AAward	+78.4K sh	—	—	2,508,620
2026-01-02	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+176K sh	—	—	176,300
2025-10-28	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−39K sh	$35.01	−$1.36M	2,419,109
2025-10-27	VKTXViking Therapeutics, Inc.A Award	Director, President & CEO	AAward	+70.1K sh	—	—	2,458,098
2025-07-03	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−26.9K sh	$27.80	−$748K	2,388,014
2025-07-02	VKTXViking Therapeutics, Inc.A Award	Director, President & CEO	AAward	+48.3K sh	—	—	2,414,903
2025-01-06	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−19K sh	$43.32	−$823K	2,366,570
2025-01-06	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−175K sh	$42.68	−$7.49M	2,385,570
2025-01-03	VKTXViking Therapeutics, Inc.A Award	Director, President & CEO	AAward	+92.8K sh	—	—	2,397,727
2025-01-03	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+78.3K sh	—	—	78,300
2025-01-03	VKTXViking Therapeutics, Inc.A Award	Director, President & CEO	AAward	+163K sh	—	—	2,561,060
2024-09-20	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−166K sh	—	—	65,000
2024-09-20	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−200 sh	$71.98	−$14.4K	2,304,927
2024-09-20	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−120K sh	$71.15	−$8.53M	2,305,127
2024-09-20	VKTXViking Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+166K sh	$7.77	+$1.29M	2,521,057
2024-09-20	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−96.1K sh	$70.43	−$6.77M	2,425,001
2024-08-21	VKTXViking Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+1,000 sh	$7.77	+$7,770	2,355,927
2024-08-21	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−1,000 sh	—	—	231,130
2024-08-21	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−1,000 sh	$69.90	−$69.9K	2,354,927
2024-08-19	VKTXViking Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+113K sh	$7.77	+$877K	2,467,797
2024-08-19	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−70.1K sh	$65.33	−$4.58M	2,397,665
2024-08-19	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−31.4K sh	$66.37	−$2.09M	2,366,223
2024-08-19	VKTXViking Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−113K sh	—	—	232,130
2024-08-19	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−11.3K sh	$67.12	−$758K	2,354,927
2024-07-30	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−30.4K sh	$58.78	−$1.79M	2,354,927
2024-07-30	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−19.5K sh	$57.81	−$1.13M	2,385,344
2024-07-30	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−65.9K sh	$56.95	−$3.76M	2,404,845
2024-07-29	VKTXViking Therapeutics, Inc.A Award	Director, President & CEO	AAward	+163K sh	—	—	2,470,786
2024-07-29	VKTXViking Therapeutics, Inc.A Award	Director, President & CEO	AAward	+41K sh	—	—	2,307,453
2024-03-27	VKTXViking Therapeutics, Inc.A Award	Director, President & CEO	AAward	+222K sh	—	—	2,420,401
2024-03-27	VKTXViking Therapeutics, Inc.F Tax Payment	Director, President & CEO	FTax Payment	−154K sh	$83.34	−$12.8M	2,266,453
2024-03-01	VKTXViking Therapeutics, Inc.F Tax Payment	Director, President & CEO	FTax Payment	−163K sh	$85.22	−$13.9M	2,198,734
2024-03-01	VKTXViking Therapeutics, Inc.A Award	Director, President & CEO	AAward	+222K sh	—	—	2,361,549
2024-02-09	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−45K sh	$29.90	−$1.35M	2,139,882
2024-02-08	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−60K sh	$25.95	−$1.56M	2,344,882
2024-02-08	VKTXViking Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+140K sh	$4.65	+$651K	2,404,882
2024-02-08	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−49.1K sh	$25.75	−$1.26M	2,264,882
2024-02-08	VKTXViking Therapeutics, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+49.1K sh	$1.23	+$60.4K	2,313,961
2024-02-08	VKTXViking Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−140K sh	—	—	0
2024-02-08	VKTXViking Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−34.9K sh	—	—	0
2024-02-08	VKTXViking Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−14.1K sh	—	—	0
2024-02-08	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−40K sh	$28.90	−$1.16M	2,184,882
2024-02-08	VKTXViking Therapeutics, Inc.S Sale	Director, President & CEO	SSale	−40K sh	$27.45	−$1.1M	2,224,882

Recent filings

Accepted (ET)
Jul 294
Lian Brian0001193125-26-324448
SEC(opens sec.gov)
Jan 54
Lian Brian0001193125-26-003113
SEC(opens sec.gov)
Oct 284
Lian Brian0001193125-25-254299
SEC(opens sec.gov)
Jul 34
Lian Brian0000950170-25-093793
SEC(opens sec.gov)
Jan 64
Lian Brian0000950170-25-002487
SEC(opens sec.gov)
Sep 204
Lian Brian0000950170-24-108576
SEC(opens sec.gov)

Companies

Address

C/O VIKING THERAPEUTICS, INC. 9920 PACIFIC HEIGHTS BLVD, SUITE 350

SAN DIEGO, CA, 92121